Archive Category: 10X Stocks Archive

In last week’s update, I assured you that Hims & Hers Health (HIMS) was poised for a major breakout after finding support at the $25 level. It was one of many times I’ve reaffirmed my strong belief that the stock is still a “good buy” since I originally recommended it in August 2022 at less than $7 a share. Well, on Monday, shares of HIMS rocketed more than 30% higher on the announcement of a new deal with Novo Nordisk A/S (NOV), which will put Novo’s blockbuster drug Wegovy on Hims’ platform as early as this week.

Hims & Hers Health (HIMS) has been one of our best-performing holdings since I first added it to the 10X Stocks portfolio two-and-a-half years ago. But 2025 has dealt a vicious “one-two” punch to our favorite telehealth company, combining a declining stock market with the recent revocation of HIMS’ ability to offer GLP-1 weight loss drugs. The result has been a significant drawdown in HIMS’ share price, even though the stock is still up over 126% in the last year.

Right now, the stock market is locked in what many experts agree to be a “Bull Crash.” That’s generally defined as a short-term period of pain that sets up an opportunity for a much bigger and better bull market later on. (If you’d like to learn more, I urge you to watch the replay of my Emergency Bull Crash Summit. It just aired earlier this afternoon…)

Hello, 10Xers! I’m here a day early with a special video update regarding global markets, stocks, President Trump’s tariff plan, and why we’re holding steady despite volatile market environments. Markets were still spiraling when I hit “record” on this video. By the time I was done, the S&P 500 had spiked on Trump’s announcement of a 90-day tariff freeze. The index closed up more than 9% on the day … which ultimately lends proof to some of our observations on volatility.

Stocks are reeling today following the “Liberation Day” announcement of President Trump’s sweeping new tariff policy. Once this new policy is in place, the U.S. will effectively be imposing a 29% average tariff rate on imports across the board … and that’s transformative in ways that most people can’t begin to fathom. I’m keeping a close eye on the broader tariff story, and it’s going to be the focus of next week’s update.